Clinical Trial Update: A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates YL201 is being studied in combination with other anti-cancer therapies for patients with advanced solid tumors, including small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Small Cell Lung Carcinoma

Drugs mentioned

• YL201

Snippet

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. | Conditions: Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma | Phase 1, Phase 2 | Status: RECRUITING